Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Heparin-Induced Thrombocytopenia”

50 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 50 results

Large-scale testing (Phase 3)Study completedNCT00043940
What this trial is testing

Anticoagulant Therapy With Bivalirudin in the Performance of Percutaneous Coronary Intervention in Patients With Heparin-Induced Thrombocytopenia (AT BAT, First Inning)

Who this might be right for
Heparin-Induced ThrombocytopeniaThrombosis
The Medicines Company 50
Not applicableEnded earlyNCT00594685
What this trial is testing

Evaluating the Presence of Blood Clots in People With Heparin-Induced Thrombocytopenia (HIT) (The HOT Study)

Who this might be right for
Thrombocytopenia
Carelon Research 10
Testing effectiveness (Phase 2)Ended earlyNCT05785819
What this trial is testing

VLX-1005 Versus Placebo in Suspected Heparin Induced Thrombocytopenia

Who this might be right for
Thrombocytopenia, ImmuneHeparin Induced Thrombocytopenia
Veralox Therapeutics 24
Early research (Phase 1)Study completedNCT05325346
What this trial is testing

A Phase I Study of the Co-administration of VLX-1005 and Argatroban in Healthy Human Subjects

Who this might be right for
Heparin-induced Thrombocytopenia
Veralox Therapeutics 12
Post-approval studies (Phase 4)Study completedNCT00039858
What this trial is testing

Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin

Who this might be right for
ThrombocytopeniaThrombosis
Encysive Pharmaceuticals 24
Not applicableUnknownNCT05783895
What this trial is testing

Comparison of Pre-test Probability Model for Heparin-induced Thrombocytopenia in Post-operative Cardiac Surgery

Who this might be right for
Heparin-induced Thrombocytopenia
Central Hospital, Nancy, France 200
Not applicableLooking for participantsNCT06033300
What this trial is testing

Characterization and Quantification of Platelet/Leukocyte Aggregates in Patients With Suspected Heparin-induced Thrombocytopenia

Who this might be right for
Heparin-induced ThrombocytopeniaHITPlatelet Activation+5 more
Centre Hospitalier Universitaire, Amiens 200
Not applicableUnknownNCT05586854
What this trial is testing

Multicenter Study on Dialysis Modalities for End-stage Chronic Renal Failure Patients With Heparin-induced Thrombocytopenia

Who this might be right for
Dialysis; ComplicationsHeparin-induced ThrombocytopeniaChronic Renal Failure
Ramsay Générale de Santé 20
Not applicableUnknownNCT00198575
What this trial is testing

A Study on the Prevalence of Heparin-Induced Thrombocytopenia in Cardiovascular Patients

Who this might be right for
Heparin-Induced Thrombocytopenia
Ministry of Health, Labour and Welfare, Japan 1,500
Not applicableStudy completedNCT00748839
What this trial is testing

Heparin-Induced Thrombocytopenia: Development and Validation of a Predictive Clinical

Who this might be right for
Heparin-induced Thrombocytopenia
Centre Hospitalier Universitaire de Saint Etienne 2,700
Not applicableStudy completedNCT05439265
What this trial is testing

EMR Tool Impact on HIT Documentation and Management

Who this might be right for
HeparinThrombocytopeniaElectronic Health Records
Rush University Medical Center 128
Large-scale testing (Phase 3)Study completedNCT00073580
What this trial is testing

Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE)

Who this might be right for
ThrombocytopeniaThrombosisCardiac Disease+1 more
The Medicines Company 88
Post-approval studies (Phase 4)Ended earlyNCT00798525
What this trial is testing

Argatroban Versus Lepirudin in Critically Ill Patients

Who this might be right for
Heparin Induced Thrombocytopenia (HIT)
Heinrich-Heine University, Duesseldorf 70
Not applicableStudy completedNCT00456001
What this trial is testing

Heparin Induced Thrombocytopenia: Pharmacoeconomics

Who this might be right for
Heparin Induced Thrombocytopenia (HIT)
Brigham and Women's Hospital 200
Post-approval studies (Phase 4)Ended earlyNCT00787332
What this trial is testing

A Comparative Sudy Comparing Argatroban® IV vs Desirudin SC for Suspected HIT With or Without Thrombosis Syndrome

Who this might be right for
Suspected Heparin-Induced Thrombocytopenia
Canyon Pharmaceuticals, Inc. 16
Not applicableUnknownNCT00946400
What this trial is testing

Validating 4Ts for Heparin Induced Thrombocytopenia (HIT)

Who this might be right for
Heparin-Induced Thrombocytopenia
Medstar Health Research Institute 500
Not applicableStudy completedNCT00456326
What this trial is testing

Heparin-Induced Thrombocytopenia Registry

Who this might be right for
Heparin-Induced Thrombocytopenia
Brigham and Women's Hospital 242
Early research (Phase 1)Study completedNCT00412464
What this trial is testing

Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis

Who this might be right for
ThrombosisHeparin-induced Thrombocytopenia
Children's Hospital Los Angeles 24
Large-scale testing (Phase 3)Ended earlyNCT01598168
What this trial is testing

Rivaroxaban for Treatment of Patients With Suspected or Confirmed Heparin-Induced Thrombocytopenia

Who this might be right for
Heparin-induced Thrombocytopenia
McMaster University 22
Not applicableStudy completedNCT01654848
What this trial is testing

Heparin-induced Thrombocytopenia (HIT II) in Liver Transplant Recipients

Who this might be right for
Heparin-induced ThrombocytopeniaLiver Transplantation
CHIR-Net 39
Load More Results